| License: Creative Commons Attribution 4.0 PDF - Published Version (381kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-520365
- DOI to cite this document:
- 10.5283/epub.52036
Abstract
The current antimicrobial therapy of bacterial infections of the central nervous system (CNS) in adults and pediatric patients is faced with many pitfalls as the drugs have to reach necessary levels in serum and cross the blood-brain barrier. Furthermore, several studies report that different factors such as the structure of the antimicrobial agent, the severity of disease, or the degree of ...
Owner only: item control page